Emesis due to cancer chemotherapy: Results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting
- 1 December 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (12), 1481-1484
- https://doi.org/10.1016/0277-5379(84)90140-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Optimizing Metoclopramide Control of Cisplatin-Induced EmesisAnnals of Internal Medicine, 1984
- MetoclopramideDrugs, 1983
- Cannabis and cancer chemotherapy. A comparison of oral delta-9-thc and prochlorperazineCancer, 1982
- Intravenous metoclopramide. An effective antiemetic in cancer chemotherapyJAMA, 1982
- ANTIEMETICS: NEUROTRANSMITTER RECEPTOR BINDING PREDICTS THERAPEUTIC ACTIONSThe Lancet, 1982
- High-dose dexamethasone for prevention of cis-platin-induced vomitingCancer Chemotherapy and Pharmacology, 1981
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- The Control of Chemotherapy-Induced EmesisAnnals of Internal Medicine, 1981
- Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.BMJ, 1979